{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Adjuvant treatment of adult and pediatric (12 years and older) patients with Stage IIB, IIC, or III melanoma following complete resection",
    "geneContextQualifier": "--",
    "objectTherapeutic": "Pembrolizumab [Keytruda]"
}